Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements

Cell Cycle

Volumn 4, Issue 10, 2005, Pages 1327-1331

  Mai, Sabine ^a   Garini, Yuval ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

3D nucleus; Brakage bridge fusion cycle; c Myc; Chromosomes; Genomic instability; Oncogene; Telomeres; Translocation

Indexed keywords

CELL NUCLEUS; CHROMOSOME REARRANGEMENT; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR MODEL; NONHUMAN; ONCOGENE; ONCOGENE C MYC; REVIEW; TELOMERE; TUMOR CELL;

EID: 26444484273     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.10.2082     Document Type: Review

References (48)

1. Zaidi SK, Young DW, Choi J-Y, Pratap J, Javed A, Montecino M, Stein JL, van Wijnen AJ, Lian JB, Stein GS. The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep 2005; 6:128-33.
2. Gilbert N, Gilchrist S, Bickmore WA. Chromatin organization in the mammalian nucleus. Int Rev Cytol 2005; 242:283-336.
3. Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 2000; 14:2855-68.
4. Nagele R, Freeman T, McMorrow L, Lee HY. Precise spatial positioning of chromosomes during prometaphase: Evidence for chromosomal order. Science 1995; 270:1831-5.
5. Cremer M, von Hase J, Volm T, Brero A, Kreth G, Walter J, Fischer C, Solovei I, Cremer C, Cremer T. Nonrandom radial higher-order chromatin arrangements in nuclei of diploid human cells. Chromosome Res 2001; 9:541-67.
6. Cremer T, Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet 2001; 4:292-301.
7. Parada LA, McQueen PG, Munson PJ, Misteli T. Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol 2002; 12:1692-7.
8. Parada L, Misteli T. Chromosome positioning in the interphase nucleus. Trends Cell Biol 2002; 12:425-32.
9. Bolzer A, Kreth G, Solvei I, Koehler D, Saracoglu K, Fauth C, Muller S, Eils R, Cremer C, Speicher MR, Cremer T. Three-dimensional maps of all chromosomes in human female fibroblast nuclei and prometaphase rosettes. PLOS Biol 2005; 3:e157.
10. Parada LA, McQueen PG, Misteli T. Tissue-specific spatial organization of genomes. Genome Biol 2004; 5(7):R44, (Epub 2004 Jun 21).
11. Tanabe H, Muller S, Neusser M, von Hase J, Calcagno E, Cremer M, Solovei I, Cremer C, Cremer T. Evolutionary conservation of chromosome territory arrangements in cell nuclei from higher primates. Proc Natl Acad Sci USA 2002; 99:4424-9.
12. Cremer T, Cremer C, Baumann H, Luedtke EK, Sperling K, Teuber V, Zorn C. Rabl's model of the interphase chromosome arrangement tested in Chinese hamster cells by premature chromosome condensation and laser-UV-microbeam experiments. Hum Genet 1982; 60:46-56.
13. Ferguson M, Ward DC. Cell cycle dependent chromosomal movement in premitotic human T-lymphocyte nuclei. Chromosoma 1992; 101:557-65.
14. Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 1999; 145:1119-31.
15. Cremer M, Kupper K, Wagler B, Wizelman L, von Hase J, Weiland Y, Kreja L, Diebold J, Speicher MR, Cremer T. Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei. J Cell Biol 2003; 162:809-20.
16. Khan MA, Walsh PC, Miller MC, Bales WD, Epstein JI, Mangold LA, Partin AW, Veltri RW. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastsis and death in men with biochemical recurrence after radical prostatectomey. Cancer 2003; 98:2583-91.
17. Kazanowska B, Jelen M, Reich A, Tarnawski W, Chybicka A. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children. Histopathology 2004; 45:352-9.
18. Nafe R, Schlote W, Schneider B. Histomorphometry of tumour cell nuclei in astrocytomas using shape analysis, densitometry and topometric nanalysis. Neuropathol Appl Neurobiol 2005; 31:34-44.
19. Chuang TCY, Moshir S, Garini Y, Chuang AYC, IT Young, van den Doel R, Mougey V, Perrin M, Braun M, Kerr DP, Fest T, Boukamp P, Mai S. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biology 2004; 2:12.
20. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Zelda Lichtensztejn Z, Fabien Kuttler F, Chuang TCY, Moshir S, Mougey V, Chuang, AYC, Kerr PD, Fest T, Boukamp P, Mai S. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005; 102:9613-8.
21. Nesbit CE, Tersak JM, Prochownik EV. Related articles, links abstract MYC oncogenes and human neoplastic disease. Oncogene 1999; 18:3004-16.
22. Mai S, Mushinski JF. c-Myc-dependent genomic instability. J Environ Path Toxicol Oncol 2003; 22:179-99.
23. Kuttler F, Mai S. c-Myc, genomic instability and disease. In: Volff J-N, ed. Genome dynamics. Vol 1: Genome and Disease. Wuerzburg, Germany: Karger Publishers, 2005:In press.
24. Mai S. Overexpression of c-myc precedes the amplification of the gene encoding the dihydrofolate reductase. Gene 1994; 148:253-60.
25. Mai S, Hanley-Hyde J, Fluri M. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. Oncogene 1996; 12:277-88.
26. Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, Mischak H, Stevens LM, Henderson DW, Mushinski JF. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Neoplasia 1999; 1:241-52.
27. Kuschak TI, Taylor C, McMillan-Ward E, Israels S, Henderson DW, Mushinski JF, Wright JA, Mai S. The ribonucleotide reductase R2 gene is a nontranscribed target of c-Myc-induced genomic instability. Gene 1999; 238:351-65.
28. Smith G, Dushnicki L, Smith S, Wright JA, Mai S. c-Myc-induced extrachromosomal elements carry active chromatin. Neoplasia 2003; 5:110-20.
29. Mai S, Fluri M, Siwarski D, Huppi K. Genomic instability in MycER activated Rat1A-MycER cells. Chromosome Res 1996; 4:365-71.
30. Rockwood LD, Torrey TA, Kim JS, Coleman AE, Kovalchuk AL, Xiang S, Ried T, Morse IIIrd HC, Janz S. Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations. Oncogene 2002; 21:7235-40.
31. Kuschak TI, Taylor C, Wright JA, Wiener F, Mai S. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene. Oncogene 2002; 21:909-20.
32. Felsher DW, Bishop JM. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 1999; 96:3940-4.
33. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol Cell 2002; 9:1031-44.
34. Hironaka K, Factor VM, Calvisi DF, Conner EA, Thorgeirsson SS. Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. Lab Invest 2003; 83:643-54.
35. Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW. Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc Natl Acad Sci USA 2003; 100:9974-9.
36. Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001; 277:1-14.
37. Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: MarvelouslY Complex. Adv Cancer Res 2002; 84:81-154.
38. Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, Thomas-Tikhonenko A. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype. Cell Growth Differ 2000; 11:201-10.
39. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. c-Myc is essential for vaculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002; 16:2530-43.
40. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22:9007-21.
41. Pelengaris S, Khan M, Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2002; 2:764-76.
42. Staege MS, Lee SP, Frisan T. Mautner J, Scholz S, Pajic A, Rickinson AB, Muscci MG, Polack A, Bornkamm GW. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. Proc Natl Acad Sci USA 2002; 99:4550-5.
43. Mueller HJ. The remaking of chromosomes. Collecting Net 1938; 13:181-98.
44. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26:234-82.
45. Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TCY, Chuang AYC, Wark L, Young IT. Characterizing the three-dimensional organization of telomeres. Cytometry 2005; In press.
46. Laitinen J, Sistonen L, Alitalo K, Holtta E. c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts. J Cell Biol 1990; 111:9-17.
47. Mello ML, de Campos Vidal B, Russo J. Ha-ras oncogene effect on DNA content and chromatin supraorganization in benzo[a]pyrene-transformed human breast epithelial cells. Anal Cell Pathol 1999; 19:73-9.
48. Helias-Rodzewicz Z, Bocian E, Stankiewicz P, Oberstyn E, Kostyk E, Jakubow-Durska K, Kutowska-Kazmierczak A, Mazurczak T. Subtelomeric rearrangements detected by FISH in three of 33 families with idiopathic mental retardation and minor physical anomalies. J Med Genet 2005; 39:e53.